Hefnawy Group
↗Cairo, Egypt
Hefnawy Group is a diversified Egyptian conglomerate with significant interests in the healthcare, pharmaceutical, and medical device sectors. The group operates as a strategic partner for international healthcare brands, providing distribution, marketing, and regulatory support within the Egyptian and MENA markets.
Through its subsidiaries, such as Marvel Medical Scientific Solutions, the group provides advanced medical technologies, scientific laboratory equipment, and healthcare management services. The group is also associated with industrial activities in the Suez Canal Economic Zone (SCZone), including chemical trading and potentially local manufacturing of medical supplies.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Healthcare Distribution & Medical Devices
SIZE & FINANCIALS
Employees:201-500
Revenue:$10M-$50M (estimated)
Founded:1982
Ownership:private
Status:operating
FUNDING
Stage:Late Stage / Profitable
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Distribution)
Modalities:Medical Devices, Diagnostic Equipment, Small Molecule (Distribution), Scientific Solutions
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Marvel Medical Scientific Solutions, Al Hefnawy Group For Chemical Trading, Hefnawy Group for Real Estate (Affiliate)
Key Partnerships:Orascom Industrial Park (SIDC), Various international medical device manufacturers
COMPETITION
Position:Niche Player
Competitors:Ibn Sina Pharma, Pharmoverseas, United Company for Pharmacists (UCP), Hefny Pharma Group (HPG)
LEADERSHIP
Key Executives:
Mohamed Elhefnawy - CEO
LINKS
Website:hefnawygroup.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hefnawy Group. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.